Inhibition of proteasome by bortezomib causes intracellular aggregation of hepatic serpins and increases the latent circulating form of antithrombin.

Source:http://linkedlifedata.com/resource/pubmed/id/18195690

Download in:

View as

General Info

PMID
18195690